Previous 10 | Next 10 |
BOSTON and JERUSALEM, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced the Company’s CEO Spiros Jamas will present at the H.C. Wainwright 23rd Annual Global Investment Confer...
Entera Bio Ltd. (ENTX) Q2 2021 Earnings Conference Call August 16, 2021 8:30 a.m. ET Company Participants Spiros Jamas - CEO Ramesh Ratan - US-based CFO Arthur Santora - CMO Phillip Schwartz – President, R&D Conference Call Participants Kalpit Patel – B. Riley Financial, Inc...
‒ Phase 2 EB613 Clinical Trial in Osteoporosi s Achieves 6-month Bone Mineral Density Endpoint; Primary and Key Secondary Endpoints Met ‒ ‒ Preparing for End of Phase 2 M eeting with FDA for P lanned ...
BOSTON and JERUSALEM, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced it will report business and financial results for the quarter ended June 30, 2021, on August 16, 2021, at 06:30am ET...
‒ The Study’s Primary Endpoint was Met; P1NP, a Biochemical Marker of Bone Formation, was Significantly Increased at Month 3 in EB613 2.5 mg Treatment Group Versus Placebo ‒ ‒ Full 3-Month Biochemical Markers of Bone Formation and Resorption to be Pre...
Companies engaged in developing therapies for Alzheimer's disease were among the best performing biotech stocks in the first half of the year.Cassava Sciences ([[SAVA]] -1.7%) was the best performing biotech stock in the half, with a return in the period of 1166%.A phase 3 trial of its Alzhei...
BOSTON and JERUSALEM, June 28, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced it will conduct a conference call to discuss results from its successfully completed Phase 2 clinical trial of...
Biggest Earnings Reports Earnings haven’t been at the forefront of investors’ minds but there were still a few reports worth mentioning. Nike (NYSE: NKE) did not only just ‘DO IT’, it rocked its fiscal fourth quarter earnings report, causing its shares to sur...
Should Investors Be Watching These Top Health Care Stocks Right Now? When it comes to answering the question of “ which stocks to invest in now ”, investors may want to consider health care stocks . With pharmaceutical giants and emerging names in biotech, ther...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Entera Bio (NASDAQ: ENTX ) and ENTX stock are seeing massive gains of as much as 40% at the time of writing. This move comes on extremely heavy volume, with more than 150 million shares h...
News, Short Squeeze, Breakout and More Instantly...